220 related articles for article (PubMed ID: 12769812)
1. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa.
Bailer UF; Kaye WH
Curr Drug Targets CNS Neurol Disord; 2003 Feb; 2(1):53-9. PubMed ID: 12769812
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment.
Barbarich NC; Kaye WH; Jimerson D
Curr Drug Targets CNS Neurol Disord; 2003 Feb; 2(1):61-72. PubMed ID: 12769813
[TBL] [Abstract][Full Text] [Related]
3. Neurobiology of anorexia and bulimia nervosa.
Kaye W
Physiol Behav; 2008 Apr; 94(1):121-35. PubMed ID: 18164737
[TBL] [Abstract][Full Text] [Related]
4. The role of the central nervous system in the psychoneuroendocrine disturbances of anorexia and bulimia nervosa.
Kaye WH; Gendall K; Kye C
Psychiatr Clin North Am; 1998 Jun; 21(2):381-96. PubMed ID: 9670232
[TBL] [Abstract][Full Text] [Related]
5. The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa.
Smitka K; Papezova H; Vondra K; Hill M; Hainer V; Nedvidkova J
Int J Endocrinol; 2013; 2013():483145. PubMed ID: 24106499
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide abnormalities in anorexia nervosa.
Kaye WH
Psychiatry Res; 1996 Apr; 62(1):65-74. PubMed ID: 8739116
[TBL] [Abstract][Full Text] [Related]
7. Anorexia and bulimia nervosa.
Kaye WH; Klump KL; Frank GK; Strober M
Annu Rev Med; 2000; 51():299-313. PubMed ID: 10774466
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine and Metabolic Disorders in Bulimia Nervosa.
Milano W; Capasso A
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):297-305. PubMed ID: 29231147
[TBL] [Abstract][Full Text] [Related]
9. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients.
Gendall KA; Kaye WH; Altemus M; McConaha CW; La Via MC
Biol Psychiatry; 1999 Jul; 46(2):292-9. PubMed ID: 10418705
[TBL] [Abstract][Full Text] [Related]
10. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
Kaye WH; Berrettini W; Gwirtsman H; George DT
Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides in eating disorders.
Jimerson DC; Wolfe BE
CNS Spectr; 2004 Jul; 9(7):516-22. PubMed ID: 15208511
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
Kaye WH; Berrettini WH; Gwirtsman HE; Gold PW; George DT; Jimerson DC; Ebert MH
Psychopharmacol Bull; 1989; 25(3):433-8. PubMed ID: 2533990
[TBL] [Abstract][Full Text] [Related]
13. [Roles of biologically active peptide in regulation of feeding behavior and energy homeostasis].
Sakurai T
Nihon Yakurigaku Zasshi; 2003 Sep; 122(3):236-42. PubMed ID: 12939541
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity.
Holden RJ; Pakula IS
Med Hypotheses; 1996 Dec; 47(6):423-38. PubMed ID: 8961238
[TBL] [Abstract][Full Text] [Related]
16. Orexigenic/anorexigenic signals in bulimia nervosa.
Takimoto Y; Inui A; Kumano H; Kuboki T
Curr Mol Med; 2003 Jun; 3(4):349-60. PubMed ID: 12776990
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine dysregulation of food intake in eating disorders.
Monteleone P; Castaldo E; Maj M
Regul Pept; 2008 Aug; 149(1-3):39-50. PubMed ID: 18582958
[TBL] [Abstract][Full Text] [Related]
18. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Martynska L; Chmielowska M
Neuro Endocrinol Lett; 2003 Dec; 24(6):431-4. PubMed ID: 15073570
[TBL] [Abstract][Full Text] [Related]
19. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.
Frank GK; Kaye WH; Altemus M; Greeno CG
Biol Psychiatry; 2000 Aug; 48(4):315-8. PubMed ID: 10960163
[TBL] [Abstract][Full Text] [Related]
20. [Selected issues of biological aspects of eating disorders].
Włodarczyk-Bisaga K; Bisaga A
Psychiatr Pol; 1994; 28(5):579-91. PubMed ID: 7991711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
